Quick Takeaways
- DODGE & COX filed SCHEDULE 13G/A for Elanco Animal Health Incorporated Common Stock (ELAN).
- Disclosed ownership: 14%.
- Date of event: 31 Mar 2026.
DODGE & COX - 31 Mar 2026 SCHEDULE 13G/A Report for Elanco Animal Health Incorporated Common Stock (ELAN)
- Filing Manager
- DODGE & COX
- Reporting Manager
- Dodge & Cox
- Symbol
- ELAN
- Shares outstanding
- 496,000,719 shares
- Disclosed Ownership
- 68,944,100 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2026, 12:30:54 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"DODGE & COX disclosed 14% ownership in Elanco Animal Health Incorporated Common Stock (ELAN) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 13 Feb 2026.
- Current filing was accepted on 14 May 2026, 12:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dodge & Cox | 14% | 68,944,100 | 65,566,800 | 0 | /S/ Katherine M. Primas | Chief Compliance Officer |